Global hepatitis C elimination: an investment framework-Reference-Cited by-同舟云学术

Global hepatitis C elimination: an investment framework

Published:2020-10 Issue:10 Volume:5 Page:927-939
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Pedrana Alisa,Howell Jessica,Scott Nick,Schroeder Sophia,Kuschel Christian,Lazarus Jeffrey V,Atun Rifat,Baptista-Leite Ricardo,'t Hoen Ellen,Hutchinson Sharon J,Aufegger Lisa,Peck Raquel,Sohn Annette H,Swan Tracy,Thursz Mark,Lesi Olufunmilayo,Sharma Manik,Thwaites John,Wilson David P,Hellard Margaret

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference88 articles.

1. Global health sector strategy on viral hepatitis 2016–2021,2016

2. Just 12 countries worldwide on track to eliminate hepatitis C infection by 2030, with United Kingdom, Italy and Spain among those joining the list;Murphy,2018

3. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission;Cooke;Lancet Gastroenterol Hepatol,2019

4. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories;Foreman;Lancet,2018

5. New protease inhibitors and direct-acting antivirals for hepatitis C: interferon's long goodbye;Dusheiko;Gut,2012

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Australians: a strategic plan for action;Medical Journal of Australia;2024-08-06

2. Epidemiologic and clinical updates on viral infections in Saudi Arabia;Saudi Pharmaceutical Journal;2024-07

3. The ‘missing’ in the ‘endgame’ of hepatitis C elimination: A qualitative study in New South Wales, Australia;Drug and Alcohol Review;2024-04-10

4. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions;The Lancet Gastroenterology & Hepatology;2024-04

5. Hospital-based screening outperforms primary care screening as a means of achieving hepatitis C virus micro-elimination;Infectious Diseases Now;2024-03